Location as Destiny: Identifying Geospatial Disparities in Radiation Treatment Interruption by Neighborhood, Race, and Insurance.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
15 07 2020
Historique:
received: 19 12 2019
revised: 11 02 2020
accepted: 07 03 2020
pubmed: 3 4 2020
medline: 16 2 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

Radiation therapy interruption (RTI) worsens cancer outcomes. Our purpose was to benchmark and map RTI across a region in the United States with known cancer outcome disparities. All radiation therapy (RT) treatments at our academic center were cataloged. Major RTI was defined as ≥5 unplanned RT appointment cancellations. Univariate and multivariable logistic and linear regression analyses identified associated factors. Major RTI was mapped by patient residence. A 2-sided P value <.0001 was considered statistically significant. Between 2015 and 2017, a total of 3754 patients received RT, of whom 3744 were eligible for analysis: 962 patients (25.8%) had ≥2 RT interruptions and 337 patients (9%) had major RTI. Disparities in major RTI were seen across Medicaid versus commercial/Medicare insurance (22.5% vs 7.2%; P < .0001), low versus high predicted income (13.0% vs 5.9%; P < .0001), Black versus White race (12.0% vs 6.6%; P < .0001), and urban versus suburban treatment location (12.0% vs 6.3%; P < .0001). On multivariable analysis, increased odds of major RTI were seen for Medicaid patients (odds ratio [OR], 3.35; 95% confidence interval [CI], 2.25-5.00; P < .0001) versus those with commercial/Medicare insurance and for head and neck (OR, 3.74; 95% CI, 2.56-5.46; P < .0001), gynecologic (OR, 3.28; 95% CI, 2.09-5.15; P < .0001), and lung cancers (OR, 3.12; 95% CI, 1.96-4.97; P < .0001) compared with breast cancer. Major RTI was mapped to urban, majority Black, low-income neighborhoods and to rural, majority White, low-income regions. Radiation treatment interruption disproportionately affects financially and socially vulnerable patient populations and maps to high-poverty neighborhoods. Geospatial mapping affords an opportunity to correlate RT access on a neighborhood level to inform potential intervention strategies.

Identifiants

pubmed: 32234552
pii: S0360-3016(20)30940-8
doi: 10.1016/j.ijrobp.2020.03.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

815-826

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Daniel V Wakefield (DV)

Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, Tennessee; T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts.

Matthew Carnell (M)

University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee.

Austin P H Dove (APH)

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.

Drucilla Y Edmonston (DY)

Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, Tennessee.

Wesley B Garner (WB)

Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, Tennessee.

Adam Hubler (A)

University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee.

Lydia Makepeace (L)

University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee.

Ryan Hanson (R)

Department of Earth Sciences, Spatial Analysis and Geographic Education Laboratory, University of Memphis, Memphis, Tennessee.

Esra Ozdenerol (E)

Department of Earth Sciences, Spatial Analysis and Geographic Education Laboratory, University of Memphis, Memphis, Tennessee.

Stephen G Chun (SG)

Division of Radiation Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas.

Sharon Spencer (S)

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

Maria Pisu (M)

Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Michelle Martin (M)

Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.

Bo Jiang (B)

Department of Radiation Oncology, Biostatistics, University of Tennessee Health Science Center, Memphis, Tennessee.

Rinaa S Punglia (RS)

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

David L Schwartz (DL)

Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, Tennessee; Division of Radiation Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee. Electronic address: dschwar4@uthsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH